Univ.-Prof.in Priv.-Doz.in Dr.in med. Julia Furtner-Srajer, PhD MBA

Deputy Head of MIAAI (Medical Image Analysis & Artificial Intelligence)


Professor Julia Furtner-Srajer is Professor of Radiology at the Danube Private University and Deputy Head of the MIAAI.


She received her medical training at the Medical University of Vienna, completing a PhD thesis on the Clinical Neurosciences doctoral programme, and was formerly head of the intraoperative MRI, the neuroradiological PET/MRI and the neurooncological imaging research group at the Medical University of Vienna.


Professor Furtner-Srajer is board member of several national and international societies, including the ÖGNR (Austrian Neuroradiology Society), the Brain Tumour Group and Imaging Group of the EORTC (European Organisation of Research and Treatment of Cancer), EURACAN (European Reference Network on Rare Adult Cancers), the ESMO (European Society of Medical Oncology) Brain Tumour Group and COST (European Cooperation in Science and Technology).


She has authored over 100 peer-reviewed articles and serves as Associate Editor of the journal Frontiers in Radiology. Her research focuses on advanced neuro-oncology imaging and imaging biomarkers.




Key publications

Trastuzumab deruxtecan in HER2-positive breast cancer wit brain metastases: a single-arm, phase 2 trial.

UBartsch R, Berhoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M.


Nature Medicine 2022 Sep; 28(9):1840-1847; DOI: 10.1038/s41591-022-01935-8



The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.


Nature Medicine 2018 Oct;24(10):1611-1624; DOI: 10.1038/s41591-018-0156


Temporal muscle Thickness as a Prognostic Marker in Patients with newly diagnosed glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071-22072 and CORE trials

Furtner J, Weller M, Weber M, Gorlia T, Nabors B, Reardon DA, Tonn JC, Stupp R, Preusser M, EORTC Brain Tumor Group


Clinical Cancer Research 2022 Jan;1;28(1):129-136; DOI:10.1158/1078-0421.CCR-21-1987


Distributed changes of the functional connectome in patients with glioblastoma

Furtner J, Nenning KH, Kiesel B, Schwartz E, Roetzer T, Fortelny N, Bock C, Grisold A, Marko M, Leutmezer F, Liu H, Golland P, Stoecklein S, Hainfellner JA, Kasprian G, Prayer D, Marosi C, Widhalm G, Woehrer A, Langs G.


Scientific Report 2020 Oct 27;10(1):18312; DOI:10.1038/s41598-020-74726-1


Robust Deep Learning-based segmentation of glioblastoma on routine clinical MRI scans using Sparsified training

Eijgelaar RS, Visser M, Müller DMJ, Barkhof F, Vrenken H, van Herk M, Bello L, Nibali MC, Rossi M, Sciorino T,Berger MS, Hervey-Jumper S, Kiesel B, Widhalm G, Furtner J, Rober PAJT, Mandonnet E, De Witt Hamer PC, De Munck JC, Witte MG


Radiology Artificial Intelligence 2020 Sep 30;2(5):e190103; DOI: 10.1148/ryai.2020190103


Multi-Habitat radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with clinical and genomic significance

Choi SW, Cho HH, Koo H, Cho KR, Nenning KH, Langs G, Furtner J, Baumann B, Woehrer A, Cho HJ, Sa JK, Kong DS, Seol HJ, Lee JI, Man DH, Park H


Cancers 2020 Jun 27;12(7):1707; DOI: 10.3390/cancers12071707



Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO II or III meningioma

Furtner J, Schöpf V, Seystahl K, Le Rhun E, Rudà R, Roelcke U, Koeppen S, Berghoff AS, Marosi C, Clement P, Faedi M, Watts C, Wick W, Soffietti R, Weller M, Preusser M.


Neuro Oncology 2016 Mar;18(3):401-7. DOI: 10.1093/neuonc/nov183


Arterial Spin-Labeling Assessment of Normalized Vascular Intratumoral Signal Intensity as a Predictor of Histologic Grade of Astrocytic Neoplasms.

Furtner J, Schöpf V, Schewzow K, Kasprian G, Weber M, Woitek R, Asenbaum U, Preusser M, Marosi C, Hainfellner JA, Widhalm G, Wolfsberger S, Prayer D.


AJNR American Journal of Neuroradiology. 2014 Mar;35(3):482-9; DOI: 10.3174/ajnr.A3705